Optimizing Breast Cancer Care Through Multidisciplinary Team Meetings
Enhance breast cancer patient care by exploring the role of oncologists, the necessity of discussing diagnoses at MDTMs, the involvement of oncologists in treatment decisions, and the importance of post-op and recurrence discussions in MDTMs.
Uploaded on | 0 Views
Download Presentation
Please find below an Image/Link to download the presentation.
The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author. If you encounter any issues during the download, it is possible that the publisher has removed the file from their server.
You are allowed to download the files provided on this website for personal or commercial use, subject to the condition that they are used lawfully. All files are the property of their respective owners.
The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author.
E N D
Presentation Transcript
Breast Multidisciplinary Team Meetings Oncology Survey
Your Role What is your current role? A. Clinical Oncologist B. Medical Oncologist C. Other
Diagnosis Should all patients undergoing needle biopsy or open surgical diagnostic biopsy be formally discussed at a MDTM ? A. Yes B. No C. Not Certain
Diagnosis Does an Oncologist need to be present for that discussion ? A. Yes B. No C. Not Certain
New Breast Cancer Diagnoses Should all newly diagnosed breast cancer cases be formally discussed at a MDTM before commencement of treatment ? A. Yes B. No C. Not Certain
New Breast Cancer Diagnoses Does an Oncologist need to be present at a MDTM to discuss ALL newly diagnosed breast cancer cases before the commencement of treatment ? A. Yes B. No C. Not Certain
New Breast Cancer Diagnoses Does an Oncologist need to be present at a MDTM to discuss newly diagnosed breast cancer cases where neoadjuvant treatment is being considered as an option ? A. Yes B. No C. Not Certain
Post Op Should all breast cancer cases undergoing surgery be formally discussed at a MDTM following surgery ? A. Yes B. No C. Not Certain
Post Op Does an Oncologist need to be present for that discussion ? A. Yes B. No C. Not Certain
Breast Cancer Recurrence Should all breast cancer cases of recurrent breast cancer be formally discussed at a MDTM ? A. Yes B. No C. Not Certain
Breast Cancer Recurrence Does an Oncologist need to be present for that discussion ? A. Yes B. No C. Not Certain
MDTM Transformation Would you be in favour of a reformed MDM system where only a small number of selected cases are formally discussed at a MDTM ? The majority of cases being placed on pre-agreed, recognised treatment algorithms / pathways A. Yes B. No C. Not Certain
Have your say - MDTM Toolkit Please contribute your ideas to improve MDTM efficiency and if applicable give examples of changes made to your Breast MDTMs that may have already made them more efficient Please email your views / examples to: mdtmtoolkit@gmail.com
